Condition: Giant Cell Tumor of Bone · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
The purpose of this study is to investigate whether zoledronic acid-loaded bone cement (4mg ZOL+ gentamicin PMMA ) as adjuvant method can decrease local recurrence in patients with giant cell bone tumor following intralesional curettage surgery. The hypothesis is that patients with local administration of zoledronic acid to the bone cement has lower relapse rate compared those with traditional bone cement(gentamicin PMMA ).
This description comes directly from the study's public registry record.
Meng Liu, MD · 13515711791 · liumeng80@163.com
Keyi Wang, MS · 17398046579 · wky82630965@gmail.com
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Zhejiang University | Hangzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05595603